Medline Prepares for $5 Billion IPO as Soon as Monday
ByAinvest
Tuesday, Dec 2, 2025 5:37 pm ET1min read
BAC--
BX--
CG--
GS--
JPM--
Medline Inc., a medical supply company backed by Blackstone and Carlyle, plans to begin formal marketing for its $5 billion IPO as soon as Monday. The company had previously targeted a $5 billion listing and expects to line up $2 billion in commitments from cornerstone investors before taking orders. Medline had $20.6 billion in net sales for the nine months ended Sept. 27 and will have two classes of shares following the IPO. Goldman Sachs, Morgan Stanley, Bank of America, and JPMorgan Chase are leading the offering, which would be the largest US IPO this year.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet